TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04834128

A Phase II Safety and Tolerability Study of TCB008 in Patients With COVID-19

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“The study was stopped because of the current status of the COVID-19 epidemic in the United Kingdom, and also because the trial involved parenterally administered IMP and a period of inpatient care and extensive outpatient visits and investigations.”

The sponsor’s own words in the registry.

Life of this trial

2021202220232024Registered2021-03-29Planned start2021-12-13 (planned)Withdrawn (as of)2023-04-21

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
TC Biopharm
Sponsor type
Industry
Conditions
COVID - 19
Interventions
TCB008
Participants
0
Sites
1
Countries
United Kingdom

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.